Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
John Tsai.
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Jun;18(6):414. doi: 10.1038/d41573-019-00089-6. Nat Rev Drug Discov. 2019. PMID: 31160776 No abstract available.
An audience with...John Reed.
Reed J, Mullard A. Reed J, et al. Among authors: mullard a. Nat Rev Drug Discov. 2014 Mar;13(3):170-1. doi: 10.1038/nrd4262. Nat Rev Drug Discov. 2014. PMID: 24577393 No abstract available.
John P. A. Ioannidis.
Ioannidis JP, Mullard A. Ioannidis JP, et al. Among authors: mullard a. Nat Rev Drug Discov. 2014 May;13(5):328-9. doi: 10.1038/nrd4317. Epub 2014 Apr 22. Nat Rev Drug Discov. 2014. PMID: 24751817 No abstract available.
John-Arne Røttingen.
Mullard A. Mullard A. Nat Rev Drug Discov. 2020 May;19(5):302-303. doi: 10.1038/d41573-020-00072-6. Nat Rev Drug Discov. 2020. PMID: 32286497 No abstract available.
2018 FDA drug approvals.
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Feb;18(2):85-89. doi: 10.1038/d41573-019-00014-x. Nat Rev Drug Discov. 2019. PMID: 30710142 No abstract available.
Hal Barron.
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Mar;18(3):166-167. doi: 10.1038/d41573-019-00026-7. Nat Rev Drug Discov. 2019. PMID: 30824895 No abstract available.
Pharmaceutical market growth set to slow?
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Mar;18(3):164. doi: 10.1038/d41573-019-00028-5. Nat Rev Drug Discov. 2019. PMID: 30824897 No abstract available.
Neglected disease R&D funding hits new high.
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Mar;18(3):164. doi: 10.1038/d41573-019-00027-6. Nat Rev Drug Discov. 2019. PMID: 30824898 No abstract available.
FDA plans Office of Drug Evaluation Science.
Mullard A. Mullard A. Nat Rev Drug Discov. 2019 Mar;18(3):164. doi: 10.1038/d41573-019-00029-4. Nat Rev Drug Discov. 2019. PMID: 30824899 No abstract available.
594 results